Topical Gene Therapy B-VEC Offers New Hope for Butterfly Skin Disease
A new review confirms that beremagene geperpavec, the first FDA-approved topical gene therapy, significantly improves wound healing in dystrophic epidermolysis ...
A new review confirms that beremagene geperpavec, the first FDA-approved topical gene therapy, significantly improves wound healing in dystrophic epidermolysis ...
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
A new review charts the rapid rise of AAV-mediated OTOF gene replacement therapy, from the first human trials to the ...
JMIR Publications' latest News and Perspectives features examine shadow AI in hospitals, voice-based disease detection, griefbots, and an FDA-approved prescription ...
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
In a groundbreaking advancement that could redefine the treatment of organ injury, UCLA cardiologists have unveiled a novel therapeutic approach ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine